Results 221 to 230 of about 1,385,287 (335)

Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir–ritonavir in patients with COVID‐19

British Journal of Clinical Pharmacology, EarlyView.
Aims The repurposed use of favipiravir in COVID‐19 has been reported to have limited clinical efficacy, yet it has been widely used in some countries. Favipiravir causes mutagenesis in RNA viruses, and it is currently unknown whether it may have a measurable effect on the virus in humans.
Akosua A. Agyeman, Laura Buggiotti, Li‐An K. Brown, Jose A. Guerra‐Assuncao, Japhette E. Kembou‐Ringert, Wen Y. Mak, Judith Breuer, David M. Lowe, Joseph F. Standing, FLARE Investigators   +9 more
wiley   +1 more source

Beyond the Fellowship: Rebuilding the Pathway to Transplant Leadership. [PDF]

Cureus
Moris D, Genyk YS, Giorgakis E.
europepmc   +1 more source

International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysis. [PDF]

J Allergy Clin Immunol Glob
Heimall J, González-Granado LI, Booth C, Ip W, Kuo CY, Bakhtiar S, Ikincioğullari A, Ferrua F, Chitty-Lopez M, Bailey M, Carter P, Matthews E, Lee J, Prockop S, Gennery AR, Leiding JW.   +15 more
europepmc   +1 more source

New opportunities for bioscaffold‐enabled spinal cord injury repair

BMEMat, EarlyView.
Schematic illustration of bioscaffolds for spinal cord injury repair. We summarize the effects of bioscaffold properties on SCI repair, highlight different types of bioscaffolds, various fabrication strategies, and in vivo transformations for the clinical development of SCI‐repairing bioscaffolds.
Xiaoqing Qi, Yicheng Fu, Zhaoliang Su, Li Li, Subrata Chakrabarti, Peng Li, Yilun Wu, Fang Liu, Teng Gao, Zhifeng Dong, Lei Liu, Pei Cao   +11 more
wiley   +1 more source

Rapid flow cytometric diagnosis of XIAP deficiency. [PDF]

Pediatr Allergy Immunol
Wakatsuki R, Nishimura M, Tomomasa D, Takahashi S, Suzuki K, Kawaguchi K, Saura R, Inoue S, Takeuchi I, Arai K, Sugiyama M, Narishige Y, Oshima A, Tsumura M, Okada S, Hoshino A, Takagi M, Kanegane H.   +17 more
europepmc   +1 more source

Milestones in Transplantation: The Story so Far [PDF]

, 2001
Starzl, TE
core  

Neuronal differentiation and tissue engineering strategies for central neurous system injury repair

BMEMat, EarlyView.
This review outlines tissue engineering advances for central nervous system (CNS) injury treatment, focusing on three core components: seed cells, inductive factors, and scaffold materials, with evaluation of their respective strengths and limitations. Tissue engineering for CNS injury repair.
Zhuqing Xia, Jinghui Zhang, Na Ren, Shuping Wang, Congcong Zhang, Nik Ahmad Nizam Nik Malek, Wan Hairul Anuar Kamaruddin, Chao Liu, Chunhui Sun, Jingang Wang   +9 more
wiley   +1 more source

The Top 12 Most Impactful Papers in Clinical Transplantation in 2025: TI Editors' Choice. [PDF]

Transpl Int
Berney T, Becchetti C, Bellini MI, Benning L, Berishvili E, Bestard O, Bos S, Brouard S, Casiraghi F, Citro A, Couzi L, Jimenez-Blanco M, Kervella D, Lim WH, Manuel O, Pilat N, Schneeberger S, Seizilles de Mazancourt E, Selzner N, Thaunat O, Toso C, Trizzino A, Yahav D, Zajacova A.   +23 more
europepmc   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

TLR8 gain-of-function: on the highway to the danger zone. [PDF]

Blood Adv
Chan AY, Dvorak CC.
europepmc   +1 more source